Clearview Wealth Advisors LLC Ocular Therapeutix, Inc Transaction History

Clearview Wealth Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$2.61 - $4.41 $751 - $1,270	-288 Reduced 38.2%	466 $1,000
Q3 2022 Oct 18, 2022	SELL	$4.09 - $6.5 $1,312 - $2,086	-321 Reduced 29.86%	754 $3,000
Q1 2022 Apr 29, 2022	SELL	$4.83 - $7.35 $879 - $1,337	-182 Reduced 14.48%	1,075 $5,000
Q2 2021 Jul 30, 2021	SELL	$13.43 - $19.16 $9,656 - $13,776	-719 Reduced 36.39%	1,257 $18,000
Q1 2021 May 06, 2021	BUY	$15.82 - $22.11 $6,565 - $9,175	415 Added 26.59%	1,976 $32,000
Q4 2020 Jan 21, 2021	BUY	$7.91 - $22.95 $12,347 - $35,824	1,561 New	1,561 $32,000

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Clearview Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Clearview Wealth Advisors LLC with notifications on news.